Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Nonparticipation reasons in a randomized international trial of a new latent tuberculosis infection regimen.

Hedges KNC, Borisov AS, Saukkonen JJ, Scott NA, Hecker EJ, Bozeman L, Dukes Hamilton C, Kerrigan A, Bessler P, Moreno-Martinez A, Arevalo B, Goldberg SV.

Clin Trials. 2019 Nov 6:1740774519885380. doi: 10.1177/1740774519885380. [Epub ahead of print]

PMID:
31690107
2.

Introduction of an Alcohol-Related Electronic Screening and Brief Intervention (eSBI) Program to Reduce Hazardous Alcohol Consumption in Namibia's Antiretroviral Treatment (ART) Program.

Tang AM, Hamunime N, Adams RA, Kanyinga G, Fischer-Walker C, Agolory S, Prybylski D, Mutenda N, Sughrue S, Walker DD, Rennie T, Zahralban-Steele M, Kerrigan A, Hong SY.

AIDS Behav. 2019 Nov;23(11):3078-3092. doi: 10.1007/s10461-019-02648-9.

3.

Developmental Dysplasia of the Hip in Patients with Connective-Tissue Disorders.

Kerrigan A, Ayeni OR, Kishta W.

JBJS Rev. 2019 Apr;7(4):e5. doi: 10.2106/JBJS.RVW.18.00092. No abstract available.

PMID:
31048628
4.

Content guidance for mobile phones short message service (SMS)-based antiretroviral therapy adherence and appointment reminders: a review of the literature.

Kerrigan A, Kaonga NN, Tang AM, Jordan MR, Hong SY.

AIDS Care. 2019 May;31(5):636-646. doi: 10.1080/09540121.2018.1549723. Epub 2018 Nov 29.

PMID:
30497271
5.

PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production.

Celada LJ, Kropski JA, Herazo-Maya JD, Luo W, Creecy A, Abad AT, Chioma OS, Lee G, Hassell NE, Shaginurova GI, Wang Y, Johnson JE, Kerrigan A, Mason WR, Baughman RP, Ayers GD, Bernard GR, Culver DA, Montgomery CG, Maher TM, Molyneaux PL, Noth I, Mutsaers SE, Prele CM, Peebles RS Jr, Newcomb DC, Kaminski N, Blackwell TS, Van Kaer L, Drake WP.

Sci Transl Med. 2018 Sep 26;10(460). pii: eaar8356. doi: 10.1126/scitranslmed.aar8356.

6.

Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure.

Jayakumar A, Savic RM, Everett CK, Benator D, Alland D, Heilig CM, Weiner M, Friedrich SO, Martinson NA, Kerrigan A, Zamudio C, Goldberg SV, Whitworth WC, Davis JL, Nahid P.

J Clin Microbiol. 2016 Dec;54(12):3028-3033. Epub 2016 Oct 12.

7.

Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada.

Moro RN, Borisov AS, Saukkonen J, Khan A, Sterling TR, Villarino ME, Scott NA, Shang N, Kerrigan A, Goldberg SV.

Clin Infect Dis. 2016 Jun 1;62(11):1390-1400. doi: 10.1093/cid/ciw126. Epub 2016 Mar 6.

8.

Obesity and normal birth: A qualitative study of clinician's management of obese pregnant women during labour.

Kerrigan A, Kingdon C, Cheyne H.

BMC Pregnancy Childbirth. 2015 Oct 12;15:256. doi: 10.1186/s12884-015-0673-2.

9.

Brain and cognition abnormalities in long-term anabolic-androgenic steroid users.

Kaufman MJ, Janes AC, Hudson JI, Brennan BP, Kanayama G, Kerrigan AR, Jensen JE, Pope HG Jr.

Drug Alcohol Depend. 2015 Jul 1;152:47-56. doi: 10.1016/j.drugalcdep.2015.04.023. Epub 2015 May 7.

10.

Cross-cultural barriers to health care.

Vidaeff AC, Kerrigan AJ, Monga M.

South Med J. 2015 Jan;108(1):1-4. doi: 10.14423/SMJ.0000000000000221. Review.

PMID:
25580748
11.

Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.

Shepardson D, Marks SM, Chesson H, Kerrigan A, Holland DP, Scott N, Tian X, Borisov AS, Shang N, Heilig CM, Sterling TR, Villarino ME, Mac Kenzie WR.

Int J Tuberc Lung Dis. 2013 Dec;17(12):1531-7. doi: 10.5588/ijtld.13.0423.

12.

Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1.

Marakalala MJ, Vautier S, Potrykus J, Walker LA, Shepardson KM, Hopke A, Mora-Montes HM, Kerrigan A, Netea MG, Murray GI, Maccallum DM, Wheeler R, Munro CA, Gow NA, Cramer RA, Brown AJ, Brown GD.

PLoS Pathog. 2013;9(4):e1003315. doi: 10.1371/journal.ppat.1003315. Epub 2013 Apr 18.

13.

Effectiveness of supported employment for veterans with spinal cord injuries: results from a randomized multisite study.

Ottomanelli L, Goetz LL, Suris A, McGeough C, Sinnott PL, Toscano R, Barnett SD, Cipher DJ, Lind LM, Dixon TM, Holmes SA, Kerrigan AJ, Thomas FP.

Arch Phys Med Rehabil. 2012 May;93(5):740-7. doi: 10.1016/j.apmr.2012.01.002.

PMID:
22541306
14.

Characterisation of innate fungal recognition in the lung.

Faro-Trindade I, Willment JA, Kerrigan AM, Redelinghuys P, Hadebe S, Reid DM, Srinivasan N, Wainwright H, Lang DM, Steele C, Brown GD.

PLoS One. 2012;7(4):e35675. doi: 10.1371/journal.pone.0035675. Epub 2012 Apr 20.

15.

Simple assays for measuring innate interactions with fungi.

Kerrigan AM, de Sousa Mda G, Brown GD.

Methods Mol Biol. 2012;845:303-17. doi: 10.1007/978-1-61779-539-8_20.

PMID:
22328383
16.

Podoplanin-expressing inflammatory macrophages activate murine platelets via CLEC-2.

Kerrigan AM, Navarro-Nuñez L, Pyz E, Finney BA, Willment JA, Watson SP, Brown GD.

J Thromb Haemost. 2012 Mar;10(3):484-6. doi: 10.1111/j.1538-7836.2011.04614.x. No abstract available.

17.

Three months of rifapentine and isoniazid for latent tuberculosis infection.

Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team.

N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875.

18.

Phagocytes: fussy about carbs.

Kerrigan AM, Brown GD.

Curr Biol. 2011 Jul 12;21(13):R500-2. doi: 10.1016/j.cub.2011.05.041.

19.

Syk-coupled C-type lectins in immunity.

Kerrigan AM, Brown GD.

Trends Immunol. 2011 Apr;32(4):151-6. doi: 10.1016/j.it.2011.01.002. Epub 2011 Feb 18. Review.

20.

Dectin-1: a role in antifungal defense and consequences of genetic polymorphisms in humans.

Marakalala MJ, Kerrigan AM, Brown GD.

Mamm Genome. 2011 Feb;22(1-2):55-65. doi: 10.1007/s00335-010-9277-3. Epub 2010 Aug 11. Review.

21.

Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs.

Kerrigan AM, Brown GD.

Immunol Rev. 2010 Mar;234(1):335-52. doi: 10.1111/j.0105-2896.2009.00882.x. Review.

PMID:
20193029
22.

Maternal serum screening: results disclosure, anxiety, and risk perception.

Czerwinski JL, Wicklund CA, Hoskovec JM, King TM, Kerrigan AJ, Mastrobattista JM.

Am J Perinatol. 2010 Apr;27(4):279-84. doi: 10.1055/s-0029-1241730. Epub 2009 Oct 15.

PMID:
19834867
23.

Complement C3 plays an essential role in the control of opportunistic fungal infections.

Tsoni SV, Kerrigan AM, Marakalala MJ, Srinivasan N, Duffield M, Taylor PR, Botto M, Steele C, Brown GD.

Infect Immun. 2009 Sep;77(9):3679-85. doi: 10.1128/IAI.00233-09. Epub 2009 Jul 6.

24.

Protein splicing of the three Pyrococcus abyssi ribonucleotide reductase inteins.

Kerrigan AM, Powers TL, Dorval DM, Reitter JN, Mills KV.

Biochem Biophys Res Commun. 2009 Sep 11;387(1):153-7. doi: 10.1016/j.bbrc.2009.06.145. Epub 2009 Jul 3.

PMID:
19577540
25.

CLEC-2 is a phagocytic activation receptor expressed on murine peripheral blood neutrophils.

Kerrigan AM, Dennehy KM, Mourão-Sá D, Faro-Trindade I, Willment JA, Taylor PR, Eble JA, Reis e Sousa C, Brown GD.

J Immunol. 2009 Apr 1;182(7):4150-7. doi: 10.4049/jimmunol.0802808.

26.

C-type lectins and phagocytosis.

Kerrigan AM, Brown GD.

Immunobiology. 2009;214(7):562-75. doi: 10.1016/j.imbio.2008.11.003. Epub 2009 Mar 3. Review.

27.

Maternal obesity and pregnancy: a retrospective study.

Kerrigan AM, Kingdon C.

Midwifery. 2010 Feb;26(1):138-46. doi: 10.1016/j.midw.2008.12.005. Epub 2009 Feb 4.

PMID:
19195748
28.

Anxiety and prenatal testing: do women with soft ultrasound findings have increased anxiety compared to women with other indications for testing?

Hoskovec J, Mastrobattista JM, Johnston D, Kerrigan A, Robbins-Furman P, Wicklund CA.

Prenat Diagn. 2008 Feb;28(2):135-40. doi: 10.1002/pd.1935.

PMID:
18236427
29.

Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors.

Dennehy KM, Ferwerda G, Faro-Trindade I, Pyz E, Willment JA, Taylor PR, Kerrigan A, Tsoni SV, Gordon S, Meyer-Wentrup F, Adema GJ, Kullberg BJ, Schweighoffer E, Tybulewicz V, Mora-Montes HM, Gow NA, Williams DL, Netea MG, Brown GD.

Eur J Immunol. 2008 Feb;38(2):500-6. doi: 10.1002/eji.200737741.

30.

Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy.

Monga U, Garber SL, Thornby J, Vallbona C, Kerrigan AJ, Monga TN, Zimmermann KP.

Arch Phys Med Rehabil. 2007 Nov;88(11):1416-22.

PMID:
17964881
31.

Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapy.

Monga U, Kerrigan AJ, Thornby J, Monga TN, Zimmermann KP.

J Rehabil Res Dev. 2005 May-Jun;42(3):391-9.

32.

Pseudo food allergy.

Teoh L, Kerrigan A, May M, Van Asperen P.

J Paediatr Child Health. 2005 Jan-Feb;41(1-2):63-4.

PMID:
15670228
33.

From work therapy to mainstream employment.

Kerrigan AJ.

Subst Use Misuse. 2004;39(13-14):2639-40. No abstract available.

PMID:
15603024
34.

Vocational rehabilitation of participants with severe substance use disorders in a VA veterans industries program.

Kerrigan AJ, Kaough JE, Wilson BL, Wilson JV, Bostick R.

Subst Use Misuse. 2004;39(13-14):2513-23.

PMID:
15603012
35.

No absolutes.

Kerrigan AT.

CMAJ. 2003 Sep 30;169(7):651; author reply 651. No abstract available. Erratum in: CMAJ. 2003 Nov 11;169(10):1010.

36.

Stress in residency: reality or myth?

Schneider KM, Monga M, Kerrigan AJ.

Am J Obstet Gynecol. 2002 May;186(5):907-9.

PMID:
12015509
37.

Vocational rehabilitation outcomes of veterans with substance use disorders in a partial hospitalization program.

Kerrigan AJ, Kaough JE, Wilson BL, Wilson JV, Boeringa JA, Monga TN.

Psychiatr Serv. 2000 Dec;51(12):1570-2.

PMID:
11097656
38.

Sexuality in persons with lower extremity amputations.

Bodenheimer C, Kerrigan AJ, Garber SL, Monga TN.

Disabil Rehabil. 2000 Jun 15;22(9):409-15.

PMID:
10894204
39.

Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy.

Monga U, Kerrigan AJ, Thornby J, Monga TN.

Radiat Oncol Investig. 1999;7(3):178-85.

PMID:
10406060
40.

Neuromuscular fatigue in prostate cancer patients undergoing radiation therapy.

Monga U, Jaweed M, Kerrigan AJ, Lawhon L, Johnson J, Vallbona C, Monga TN.

Arch Phys Med Rehabil. 1997 Sep;78(9):961-6.

PMID:
9305269
41.

Blood count and differential leucocyte count during streptomycin therapy; a review of 45 cases treated.

JULLIEN W, KERRIGAN A.

J Med Assoc Eire. 1949 Jun;24(144):86. No abstract available.

PMID:
18149290
42.

The Inheritance of the Crescent and Twin Spot Marking in Xiphophorus Helleri.

Kerrigan AM.

Genetics. 1934 Nov;19(6):581-99. No abstract available.

Supplemental Content

Loading ...
Support Center